Giovanni Di Vagno

Topotecan Compared With No Therapy After Response to Surgery and Carboplatin/Paclitaxel in Patients With Ovarian Cancer: Multicenter Italian Trials in Ovarian Cancer (MITO-1) Randomized Study

Sabino De Placido, Giovanni Scambia, Giovanni Di Vagno et al. · Journal of Clinical Oncology · 2004 · 164 citations · Full text

Conservative treatment of early endometrial cancer: Preliminary results of a pilot study

Giuseppe Laurelli, Giovanni Di Vagno, Cono Scaffa et al. · Gynecologic Oncology · 2010 · 125 citations

Gynecological Surgery, Early Endometrial Cancer, Medicine +6

Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel: The Multicenter Italian Trial in Ovarian cancer (MITO-4) retrospective study

Sandro Pignata, Sabino De Placido, R. Biamonte et al. · BMC Cancer · 2006 · 115 citations · Full text

Phase III multicenter randomized trial of amifostine as cytoprotectant in first-line chemotherapy in ovarian cancer patients

Domenica Lorusso, Gabriella Ferrandina, Stefano Greggi et al. · Annals of Oncology · 2003 · 94 citations

Phase Iii Multicenter, Medicine, Metronomic Therapy +10

Phase II Study of Cisplatin and Vinorelbine as First-Line Chemotherapy in Patients With Carcinoma of the Uterine Cervix

Sandro Pignata, Giustino Silvestro, Ettore Ferrari et al. · Journal of Clinical Oncology · 1999 · 72 citations